321125-48-8 Usage
Uses
Used in Pharmaceutical Synthesis:
1-(4-Benzyloxy-3-methoxyphenyl)-2-nitropropene is used as a key intermediate in the synthesis of various pharmaceuticals for [application reason]. Its unique chemical structure allows for the creation of a wide range of medicinal compounds, contributing to the development of novel treatments and therapies.
Used in Organic Product Synthesis:
In the field of organic chemistry, 1-(4-Benzyloxy-3-methoxyphenyl)-2-nitropropene is used as a building block for the synthesis of different organic products for [application reason]. Its versatility in chemical reactions enables the production of a diverse array of organic compounds with various applications.
Used in Drug Development:
1-(4-Benzyloxy-3-methoxyphenyl)-2-nitropropene is used as a precursor in the development of new drugs for [application reason]. Its potential in creating novel chemical entities makes it a valuable asset in the pharmaceutical industry, aiding in the discovery of innovative medications.
Used in Chemical Production:
1-(4-BENZYLOXY-3-METHOXYPHENYL)-2-NITROPROPENE is also used as a precursor for the production of other important chemicals in the chemical industry for [application reason]. Its role in creating essential chemicals highlights its significance in various industrial applications.
It is crucial to note that due to the moderate toxicity of 1-(4-Benzyloxy-3-methoxyphenyl)-2-nitropropene, proper handling and safety measures should be implemented during its use in any application.
Check Digit Verification of cas no
The CAS Registry Mumber 321125-48-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,2,1,1,2 and 5 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 321125-48:
(8*3)+(7*2)+(6*1)+(5*1)+(4*2)+(3*5)+(2*4)+(1*8)=88
88 % 10 = 8
So 321125-48-8 is a valid CAS Registry Number.
321125-48-8Relevant academic research and scientific papers
Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection
-
, (2015/08/04)
The invention provides novel compounds having the general formula: wherein R1, R2, R3, R4, R5 and R6 are as described herein, compositions including the compounds and methods of using the compounds.
NOVEL DIHYDROQUINOLIZINONES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION
-
, (2015/09/23)
The invention provides novel compounds having the general formula (I) wherein R1, R2 R3, R4, R5 and R6 are as described herein, compositions including the compounds and methods of using the compounds in the treatment of the hepatitis B virus.
Amide compounds and use thereof
-
Page/Page column 19-20, (2010/01/31)
An amide compound given by formula [I]: wherein R1 represents a C1-C10 haloalkyl and so on, R2 represents a hydrogen and so on, X represents an oxygen or sulfur, Y represents an oxygen or sulfur, Ar represents an aromatic group, A represents an
Synthesis and capillary electrophoretic analysis of enantiomerically enriched reference standards of MDMA and its main metabolites
Pizarro, Nieves,De la Torre, Rafael,Farre, Magi,Segura, Jordi,Llebaria, Amadeu,Joglar, Jesus
, p. 1085 - 1092 (2007/10/03)
Enantiomerically-enriched (S)-3,4-methylenedioxymethamphetamine (MDMA) and its main metabolites (S)-4-hydroxy-3-methoxymethamphetamine (HMMA) and (S)-3,4-dihydroxymethamphetamine (HHMA) were prepared or unequivocal identification of the differential enantioselective metabolism of these compounds as well as for its application in the analysis of biological samples. Capillary electrophoresis with cyclodextrin derivatives and a chemical correlation of (S)-MDMA, (S)-HMMA and (S)-HHMA has been performed to assign the absolute stereochemistry of major isomers in analytical standards enriched with such enantiomers. Copyright
